Cys-140 Is Critical for Metabotropic Glutamate Receptor-1 Dimerization*

  1. Kausik Ray and
  2. Benjamin C. Hauschild
  1. From the Metabolic Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892

    Abstract

    Metabotropic glutamate receptor 1 (mGluR1) expresses at the cell surface as disulfide-linked dimers and can be reduced to monomers with sulfhydryl reagents. To identify the dimerization domain, we transiently expressed in HEK-293 cells a truncated version of mGluR1 (RhodC-R1) devoid of the extracellular domain (ECD). RhodC-R1 was a monomer in the absence or presence of the reducing agents, suggesting that dimerization occurs via the ECD. To identify cysteine residues involved in dimerization within the ECD, cysteine to serine point mutations were made at three cysteines within the amino-terminal half of the ECD. A mutation at positions Cys-67, Cys-109, and Cys-140 all resulted in significant amounts of monomers in the absence of reducing agents. The monomeric C67S and C109S mutants were not properly glycosylated, failed to reach the cell surface, and showed no glutamate response, indicating that these mutant receptors were improperly folded and/or processed and thus retained intracellularly. In contrast, the monomeric C140S mutant was properly glycosylated, processed, and expressed at the cell surface. Phosphoinositide hydrolysis assay showed that the glutamate response of the C140S mutant receptor was similar to the wild type receptor. Substitution of a cysteine for Ser-129, Lys-134, Asp-143, and Thr-146 on the C140S mutant background restored receptor dimerization. Taken together, the results suggest that Cys-140 contributes to intermolecular disulfide-linked dimerization of mGluR1.

    Footnotes

    • * The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • To whom correspondence should be addressed: Laboratory of Signal Transduction, National Institute on Deafness and Other Communication Disorders, 5 Research Ct., Rockville, MD 20850. Tel.: 301-496-9168; Fax: 301-480-8019; E-mail: Kray@helix.nih.gov.

    • Published, JBC Papers in Press, August 16, 2000, DOI 10.1074/jbc.M005581200

    • Abbreviations:
      mGluR

      metabotropic glutamate receptor

      GPCR

      G-protein-coupled receptor

      PhI

      phosphoinositide

      V2R

      vomeronasal organ receptor (Type 2)

      T1R

      taste receptor (Type 1)

      ECD

      extracellular domain

      HEK-293 cells

      human embryonic kidney 293 cells

      PAGE

      polyacrylamide gel electrophoresis

      PNGase-F

      peptide N-glycosidase F

      Endo-H

      endo-β-N-acetylglucosaminidase H

      Biotin-7-NHS

      d-biotinoyl-ε-aminocaproic acid-N-hydroxysuccinimide ester

      PIPES

      1,4-piperazinediethanesulfonic acid

      PCR

      polymerase chain reaction

      POD

      peroxidase-conjugated

      GABA

      γ-aminobutyric acid

      • Received June 26, 2000.
      • Revision received August 2, 2000.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement